Image-ID # 1455
With AI, the choice of drugs for patients and the adjustment of doses will be much more personalized than today, said Dr. Bence Kovács, Head of General Medicines Business Unit of Gedeon Richter Plc.
Reproduction for press purposes free of charge with credit “Picture: Bosch”